Professional Summary
Professional Overview
Marina Tort Canadas is a seasoned HEOR (Health Economics and Outcomes Research) and Pricing professional with a strong track record in the pharmaceutical industry. She specializes in market access, health economics, and pricing strategy, leveraging her expertise to drive successful market entry and reimbursement for innovative drug products.
Experience Summary
Current Role
Marina currently serves as the HEOR & Pricing Lead at Boehringer Ingelheim, a leading global pharmaceutical company. In this role, she is responsible for conducting comprehensive health economic evaluations, developing pricing strategies, and securing favorable reimbursement decisions for the company's drug portfolio. Her work has a direct impact on ensuring patient access to Boehringer Ingelheim's innovative therapies.
Career Progression
Prior to her current position, Marina held several notable roles in the field of market access and health economics. She served as a Market Access and Health Economics Consultant at Amaris, where she provided strategic guidance to pharmaceutical clients on navigating the complex reimbursement landscape and optimizing their market access strategies. Earlier in her career, she gained valuable experience as a Market Access and Health Economics Consultant at Omakase Consulting, contributing to the successful market entry of various drug products.
Marina's career began with a stint as a Junior Auditor at BDO Spain, where she honed her analytical skills and developed a strong foundation in financial analysis and reporting.
Academic Background
Marina holds a Master's degree in Health Economics and Outcomes Research from a prestigious university, where she specialized in the application of economic principles to healthcare decision-making. Her academic achievements and specialized training have equipped her with the necessary expertise to excel in the HEOR and pricing domains.
Areas of Expertise
- Health economics and outcomes research
- Pricing and reimbursement strategy
- Market access and stakeholder engagement
- Pharmaceutical product launch and commercialization
- Data analysis and evidence-based decision-making
- Strategic consulting and client relationship management
Professional Impact
Throughout her career, Marina has played a pivotal role in securing favorable reimbursement decisions for her clients' drug products, ensuring improved patient access to innovative therapies. Her work has been recognized for its strategic impact, contributing to the successful market entry and commercial success of numerous pharmaceutical products.
Conclusion
With her extensive experience, deep industry knowledge, and a proven track record of success, Marina Tort Canadas is a valuable asset in the HEOR and pricing domain. Her commitment to driving positive health outcomes and her ability to navigate the complex regulatory and reimbursement landscape make her a trusted advisor to her clients and a respected professional within the pharmaceutical industry.
